| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/21/1997 | US5595902 DNA encoding human protein kinase C (iota) |
| 01/21/1997 | US5595900 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures |
| 01/21/1997 | US5595899 Methods of introducing foreign DNA into cells |
| 01/21/1997 | US5595898 Cdna genetic sequences |
| 01/21/1997 | US5595897 Cationic polymers |
| 01/21/1997 | US5595896 Cloning genes for plants using enzymes |
| 01/21/1997 | US5595895 Efficient directional genetic cloning system |
| 01/21/1997 | US5595894 Genetic engineering with dna with plasmid containing a gene with serine |
| 01/21/1997 | US5595891 Method for producing a polynucleotide for use in single primer amplification |
| 01/21/1997 | US5595890 Method of detecting nucleotide sequences |
| 01/21/1997 | US5595889 Process for integration of a chosen gene on the chromosome of a bacterium using Mu transposons |
| 01/21/1997 | US5595888 Recombinant methods of making gamma interferon compositions |
| 01/21/1997 | US5595887 Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment |
| 01/21/1997 | US5595886 Gene expression in eukaryotic cell, treatment of hemophilia |
| 01/21/1997 | US5595885 Matrix metalloproteinase inhibitor peptides |
| 01/21/1997 | US5595884 Papillomavirus E2 transactivation repressor proteins and DNA |
| 01/21/1997 | US5595882 Angiotensin II type-1 receptor proteins and screening assays using such proteins or transformants expressing them |
| 01/21/1997 | US5595880 DNA encoding an α2B adrenergic receptor and uses thereof |
| 01/21/1997 | US5595877 Methods of producing nucleic acid ligands |
| 01/21/1997 | US5595876 Followed by modification with restriction endonuclease |
| 01/21/1997 | US5595873 T. thermophila group I introns that cleave amide bonds |
| 01/21/1997 | US5595871 Detection and prevention of mycoplasma hominis infection |
| 01/21/1997 | US5595869 Diagnostic methods for detecting lymphomas in humans |
| 01/21/1997 | US5595868 Monoclonal antibodies to hepatitis C virus |
| 01/21/1997 | US5595740 Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens |
| 01/21/1997 | US5595739 Hepatitis B virus mutants, reagents and methods for detection |
| 01/21/1997 | US5595736 Compounds and methods for treatment of thromboembolic disorders |
| 01/21/1997 | US5595733 Methods for protecting ZEA mays plants against pest damage |
| 01/21/1997 | US5595726 Porphyrin type chromophore conjugated to oligonucleotide, fluorescence, detection of tumors, screening for hiv |
| 01/21/1997 | CA2037831C Methods for the treatment of demyelinating disease, uveitis, or graft-versus-host disease |
| 01/21/1997 | CA1338859C Expression system |
| 01/21/1997 | CA1338858C Plant anaerobic regulatory element |
| 01/21/1997 | CA1338857C Yeast vector featuring antibiotic resistance and chromosomal integration |
| 01/21/1997 | CA1338856C In vivo labelling of polynucleotide sequences |
| 01/16/1997 | WO1997001647A2 Dna sequences for identifying highly transmissible lineages of pseudomonas (burkholderia) cepacia |
| 01/16/1997 | WO1997001646A2 Electrochemical detection of nucleic acid hybridization |
| 01/16/1997 | WO1997001645A1 Primer walking cycle sequencing |
| 01/16/1997 | WO1997001642A1 Modified proteins and methods of their production |
| 01/16/1997 | WO1997001641A1 STABLE TRANSFORMATION of UNDIFFERENTIATED CONIFER CELLS |
| 01/16/1997 | WO1997001640A2 Vaccines against hepatitis c |
| 01/16/1997 | WO1997001639A2 Selection of recombinant molecules |
| 01/16/1997 | WO1997001638A1 Omp26 antigen from haemophilus influenzae |
| 01/16/1997 | WO1997001637A1 Process for the microbial production of amino acids using recombinant micro-organisms with raised secretion rate |
| 01/16/1997 | WO1997001636A2 Recombinant mistletoe lectin |
| 01/16/1997 | WO1997001635A1 Bax omega protein and methods |
| 01/16/1997 | WO1997001634A2 Polypeptide for repairing genetic information, nucleotidic sequence which codes for it and process for the preparation thereof (guanine thymine binding protein - gtbp) |
| 01/16/1997 | WO1997001633A1 Cytokine that induces apoptosis |
| 01/16/1997 | WO1997001630A1 HUMAN GLANDULAR KALLIKREIN-1 (hK2) |
| 01/16/1997 | WO1997001627A1 High-level expression and efficient recovery of ubiquitin fusion proteins from escherichia coli |
| 01/16/1997 | WO1997001577A1 Ion channel |
| 01/16/1997 | WO1997001574A1 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3 |
| 01/16/1997 | WO1997001572A1 Sequences for production of 2,4-diacetylphloroglucinol and methods |
| 01/16/1997 | WO1997001571A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/16/1997 | WO1997001358A1 Tissue specific viral vectors |
| 01/16/1997 | WO1997001357A1 Encapsulated cells producing viral particles |
| 01/16/1997 | WO1997001354A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | WO1996037610A3 Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders |
| 01/16/1997 | WO1996036702A3 Soluble, active hepatitis c virus protease |
| 01/16/1997 | WO1996034954A3 Biotin-binding containment systems |
| 01/16/1997 | WO1996034935A3 Subtilisin variants |
| 01/16/1997 | WO1996034116A3 Universal targets for species identification |
| 01/16/1997 | WO1996027677A3 Method of purification of recombinant viral vectors containing a therapeutic gene |
| 01/16/1997 | DE19525416A1 Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems Use of MP52 for the treatment and prevention of diseases of the nervous system |
| 01/16/1997 | DE19525034A1 DNA-Sequenzen und ihre Verwendung DNA sequences and their use |
| 01/16/1997 | CA2225935A1 Electrochemical detection of nucleic acid hybridization |
| 01/16/1997 | CA2225405A1 Omp26 antigen from haemophilus influenzae |
| 01/16/1997 | CA2224701A1 Bax omega protein and methods |
| 01/16/1997 | CA2224662A1 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3 |
| 01/16/1997 | CA2224396A1 Primer walking cycle sequencing |
| 01/16/1997 | CA2224319A1 Human glandular kallikrein-1 (hk2) |
| 01/16/1997 | CA2222849A1 Sequences for production of 2,4-diacetylphloroglucinol and methods |
| 01/16/1997 | CA2222559A1 Encapsulated cells producing viral particles |
| 01/16/1997 | CA2222457A1 Tissue specific viral vectors |
| 01/16/1997 | CA2222456A1 Vaccines against hepatitis c |
| 01/16/1997 | CA2222024A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | CA2221294A1 Tetradotoxin insensitive sodium channel |
| 01/15/1997 | EP0753584A1 Sequencing near infrared and infrared fluorescence labeled DNA for detecting using laser diodes and suitable labels therefor |
| 01/15/1997 | EP0753581A1 Improved recombinant eukaryotic cytoplasmic viruses, method for their production and their use as vaccines |
| 01/15/1997 | EP0753580A2 Cell-specific gene therapy, using the tissue inhibitor of metalloproteinase-3 promoter |
| 01/15/1997 | EP0753579A2 Novel promoter and method of gene expression using the same |
| 01/15/1997 | EP0753578A1 Novel Bacillus thuringiensis isolate active against lepidopteran pests, and gene encoding novel lepidopteran-active toxin |
| 01/15/1997 | EP0753577A1 Cell-surface polypeptide gene |
| 01/15/1997 | EP0753312A1 Arteriosclerosis remedy |
| 01/15/1997 | EP0753248A1 Organism with inhibited expression of s-adenosylhomocysteine hydrolase gene |
| 01/15/1997 | EP0753076A1 Methods of identifying inducible inhibitors of transformation progression |
| 01/15/1997 | EP0753075A1 Method for suppressing dna fragment amplification during pcr |
| 01/15/1997 | EP0753073A1 Heat-inducible n-degron module |
| 01/15/1997 | EP0753071A1 Cell-targeted lytic pore-forming agents |
| 01/15/1997 | EP0753070A1 Novel nucleic acid/polymer complexes, method for preparing same and use thereof for cell transfection |
| 01/15/1997 | EP0753069A1 Gene delivery fusion proteins |
| 01/15/1997 | EP0753068A1 Ligands added to adenovirus fiber |
| 01/15/1997 | EP0753067A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF) |
| 01/15/1997 | EP0753066A1 Recombinant bcg vaccines |
| 01/15/1997 | EP0753064A1 Method for the permanent expression of glutamate receptors |
| 01/15/1997 | EP0753063A1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting |
| 01/15/1997 | EP0753062A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 01/15/1997 | EP0753061A1 Vaccine compositions |
| 01/15/1997 | EP0753060A1 Conserved t-cell receptor sequences |
| 01/15/1997 | EP0753059A1 Peptide production as fusion protein in transgenic mammal milk |
| 01/15/1997 | EP0753057A1 Alkaline bacillus amylase |